Skip to content

Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH

Comparison Between GnRH Agonist Long Protocol And GnRH Antagonist Protocol In Outcome Of The First Cycle ART

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00823602
Enrollment
2
Registered
2009-01-15
Start date
2008-03-31
Completion date
2009-01-31
Last updated
2009-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

GnRH antagonist, GnRH agonist, pregnancy rate, Ovarian stimulation

Brief summary

Literature suggests that GnRH antagonists are comparatively more often used in cycles which have an unfavorable prior prognosis, and this protocol is an ideal one for poor responder patients. Up to now, however not enough prospectives have been published to prove any beneficial effect of antagonists on the first cycle assisted reproductive technique. This prospective study will do to evaluate the efficacy of gonadotropin releasing hormone antagonist in comparison with the standard long protocol in the first cycle of ART. The investigators will randomize 160 patients undergoing ART for the first time . Group 1 (n=80) was stimulate with a standard long protocol and group 2 (n=80) stimulated with GnRH antagonist and then result of ART compare in two group .

Interventions

DRUGganirelix

These patients started ovarian stimulation with 150 - 225 IU Gonal F on the second day of menstrual cycle with an S.C. injection once a day. Initiation of 0.25 mg Ganirelix took place on the 6th of the stimulation (fixed protocol) when HMG (Menogon, ferring, pharmacenticals , Germany ).

DRUGsuprefact

GnRH agonist, standard protocol

Sponsors

Yazd Research & Clinical Center for Infertility
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* first cycle of ART * age \< 35 years * basal FSH \< 10 IU/L

Exclusion criteria

* previous IVF or ICSI, hyperprolactinemia, hyperthyroidism, hypothyroidism, uterine abnormality, severe endometriosis * only one ovary

Design outcomes

Primary

MeasureTime frame
pregnancy rate2weeks

Secondary

MeasureTime frame
ovarian stimulation10days

Countries

Iran

Contacts

Primary Contactrazieh firouzabadi, MD
dr_firouzabadi@yahoo.com8247085
Backup Contactshahnaz Ahmadi, MD
AHMADISHAHNAZ2005@yahoo.com9173717981

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026